Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 20, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 23, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000105770-26-000023
Filed / recorded
Feb 23, 2026, 10:40 PM UTC
Added to OQRO
Oct 2, 2026, 12:29 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
WEST PHARMACEUTICAL SERVICES INC
Issuer CIK
105770
Ticker
WST
Reporting person
Chad Winters
Relationship
Officer
Officer title
VP, Chief Accounting Officer
Security
Rst. Stock Unit
Table
Derivative (Table II)
Transaction date
Feb 20, 2026
Transaction code
M
Shares / units
89.328
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
267.972
Ownership form
Direct
Amendment
No
Footnotes from the filing
Restricted stock units convert into common stock on a one-for-one basis.
On February 18, 2025, the reporting person was granted 356 restricted stock units, vesting in four equal annual installments (plus dividend equivalents) on February 20th each year.